These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major. Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663 [TBL] [Abstract][Full Text] [Related]
4. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients. Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137 [TBL] [Abstract][Full Text] [Related]
5. No evidence for myocardial iron overload and free iron species in multitransfused patients with sickle/beta-thalassaemia. Ghoti H; Goitein O; Koren A; Levin C; Kushnir T; Rachmilewitz E; Konen E Eur J Haematol; 2010 Jan; 84(1):59-63. PubMed ID: 19793250 [TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528 [TBL] [Abstract][Full Text] [Related]
7. Correlation of hepcidin level with insulin resistance and endocrine glands function in major thalassemia. Al-Hakeim HK; Al-Khakani MM; Al-Kindi MA Adv Clin Exp Med; 2015; 24(1):69-78. PubMed ID: 25923089 [TBL] [Abstract][Full Text] [Related]
8. A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine. Moayedi B; Gharagozloo M; Esmaeil N; Maracy MR; Hoorfar H; Jalaeikar M Eur J Haematol; 2013 Mar; 90(3):202-9. PubMed ID: 23278124 [TBL] [Abstract][Full Text] [Related]
9. Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients. Said Othman KM; Elshazly SA; Heiba NM Hematology; 2014 Oct; 19(7):380-7. PubMed ID: 24225039 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic potential of hepcidin testing in pediatrics. Cangemi G; Pistorio A; Miano M; Gattorno M; Acquila M; Bicocchi MP; Gastaldi R; Riccardi F; Gatti C; Fioredda F; Calvillo M; Melioli G; Martini A; Dufour C Eur J Haematol; 2013 Apr; 90(4):323-30. PubMed ID: 23438060 [TBL] [Abstract][Full Text] [Related]
11. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection. Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485 [TBL] [Abstract][Full Text] [Related]
13. What regulates hepcidin in poly-transfused β-Thalassemia Major: erythroid drive or store drive? Chauhan R; Sharma S; Chandra J Indian J Pathol Microbiol; 2014; 57(1):39-42. PubMed ID: 24739829 [TBL] [Abstract][Full Text] [Related]
14. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications. Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856 [TBL] [Abstract][Full Text] [Related]
15. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major. Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334 [TBL] [Abstract][Full Text] [Related]
17. T2* MRI in regularly transfused children with thalassemia intermedia: serum ferritin does not reflect liver iron stores. Tony S; Daar S; Elshinawy M; Al-Zadjaly S; Al-Khabori M; Wali Y Pediatr Hematol Oncol; 2012 Sep; 29(6):579-84. PubMed ID: 22839111 [TBL] [Abstract][Full Text] [Related]
18. [Iron overload in sickle cell anemia : a study of 94 patients]. Hafsia R; Belakhal F; Ben Salah N; Gouider E; Elborgi W Tunis Med; 2011 Jun; 89(6):548-52. PubMed ID: 21681718 [TBL] [Abstract][Full Text] [Related]
19. [Detection of Hepcidin in transfusion dependent myelodysplastic syndrome patients and its clinical significance]. Qin Y; Liu H; Ruan S; Cai YF; You XF; Song GQ Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):758-61. PubMed ID: 22339912 [TBL] [Abstract][Full Text] [Related]
20. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies. Jastaniah W; Harmatz P; Pakbaz Z; Fischer R; Vichinsky E; Walters MC Pediatr Blood Cancer; 2008 Feb; 50(2):319-24. PubMed ID: 17557314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]